Leif I. Solberg

Leif I. Solberg

Auto-generated profile, based on publicly available information

Leif I. Solberg

HealthPartners Institute

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
LSLeif I. Solberg
Leif I. Solberg
MMMichael V. Maciosek
Michael V. Maciosek
NENichol M. Edwards
Nichol M. Edwards

1 April 2000 in The Joint Commission Journal on Quality Improvement
Verified
Journal Article
Closed access
LSLeif I. Solberg
Leif I. Solberg
MBMilo L. Brekke
Milo L. Brekke
CFCharles J. Fazio
Charles J. Fazio
JFJinnet Fowles
Jinnet Fowles
DJDiane N. Jacobsen
Diane N. Jacobsen
SRSharon J. Rolnick
Sharon J. Rolnick

1 July 2006 in American Journal of Medical Quality
Verified
Journal Article
Closed access
LSLeif I. Solberg
Leif I. Solberg
KEKaren I. Engebretson
Karen I. Engebretson
JSJoann M. Sperl-Hillen
Joann M. Sperl-Hillen
MHMary C. Hroscikoski
Mary C. Hroscikoski
POPatrick J. O'COnnor
Patrick J. O'COnnor
The objective of this study was to demonstrate a method to accurately identify patients with specific conditions from claims data for care improvement or performance measurement. In an iterative process of trial case definitions followed by review of repeated random samples of 10 to 20 cases for diabetes, heart disease, or newly treated depression, a final identification algorithm was created from claims files of health plan members. A final sample was used to calculate the positive predictive value (PPV). Each condition had unacceptably low PPVs (0.20, 0.60, and 0.65) when cases were identified on the basis of only 1 International Classification of Diseases, ninth revision, code per year. Requiring 2 outpatient codes or 1 inpatient code within 12 months (plus consideration of medication data for diabetes and extra criteria for depression) resulted in PPVs of 0.97, 0.95, and 0.95. This approach is feasible and necessary for those wanting to use administrative data for case identification for performance measurement or quality improvement.

30 September 2014 in Implementation Science
Verified
Journal Article
Open access
PDF file
AKAmy M Kilbourne
Amy M Kilbourne
DADaniel Almirall
Daniel Almirall
DEDaniel Eisenberg
Daniel Eisenberg
JWJeanette Waxmonsky
Jeanette Waxmonsky
DGDavid E Goodrich
David E Goodrich
MTMarshall R Thomas
Marshall R Thomas
Despite the availability of psychosocial evidence-based practices (EBPs), treatment and outcomes for persons with mental disorders remain suboptimal. Replicating Effective Programs (REP), an effective implementation strategy, still resulted in less than half of sites using an EBP. The primary aim of this cluster randomized trial is to determine, among sites not initially responding to REP, the effect of adaptive implementation strategies that begin with an External Facilitator (EF) or with an External Facilitator plus an Internal Facilitator (IF) on improved EBP use and patient outcomes in 12 months. This study employs a sequential multiple assignment randomized trial (SMART) design to build an adaptive implementation strategy. The EBP to be implemented is life goals (LG) for patients with mood disorders across 80 community-based outpatient clinics (N N = 1,600 patients) from different U.S. regions. Sites not initially responding to REP (defined as <50% patients receiving ≥3 EBP sessions) will be randomized to receive additional support from an EF or both EF/IF. Additionally, sites randomized to EF and still not responsive will be randomized to continue with EF alone or to receive EF/IF. The EF provides technical expertise in adapting LG in routine practice, whereas the on-site IF has direct reporting relationships to site leadership to support LG use in routine practice. The primary outcome is mental health-related quality of life; secondary outcomes include receipt of LG sessions, mood symptoms, implementation costs, and organizational change. This study design will determine whether an off-site EF alone versus the addition of an on-site IF improves EBP uptake and patient outcomes among sites that do not respond initially to REP. It will also examine the value of delaying the provision of EF/IF for sites that continue to not respond despite EF. ClinicalTrials.gov identifier: NCT02151331

1 March 1997 in The Joint Commission Journal on Quality Improvement
Verified
Journal Article
Closed access
LSLeif I. Solberg
Leif I. Solberg
GMGordon Mosser
Gordon Mosser
SMSharon McDonald
Sharon McDonald

6 January 2017 in The Annals of Family Medicine
Verified
Journal Article
Open access
PDF file
MMMichael V. Maciosek
Michael V. Maciosek
ALAmy B. LaFrance
Amy B. LaFrance
SDSteven P. Dehmer
Steven P. Dehmer
DMDana A. McGree
Dana A. McGree
TFThomas J. Flottemesch
Thomas J. Flottemesch
LSLeif I. Solberg
Leif I. Solberg
PURPOSE The Patient Protection and Affordable Care Act’s provisions for first-dollar coverage of evidence-based preventive services have reduced an important barrier to receipt of preventive care. Safety-net providers, however, still serve a substantial uninsured population, and clinician and patient time remain limited in all primary care settings. As a consequence, decision makers continue to set priorities to help focus their efforts. This report updates estimates of relative health impact and cost-effectiveness for evidence-based preventive services. METHODS We assessed the potential impact of 28 evidence-based clinical preventive services in terms of their cost-effectiveness and clinically preventable burden, as measured by quality-adjusted life years (QALYs) saved. Each service received 1 to 5 points on each of the 2 measures—cost-effectiveness and clinically preventable burden—for a total score ranging from 2 to 10. New microsimulation models were used to provide updated estimates of 12 of these services. Priorities for improving delivery rates were established by comparing the ranking with what is known of current delivery rates nationally. RESULTS The 3 highest-ranking services, each with a total score of 10, are immunizing children, counseling to prevent tobacco initiation among youth, and tobacco-use screening and brief intervention to encourage cessation among adults. Greatest population health improvement could be obtained from increasing utilization of clinical preventive services that address tobacco use, obesity-related behaviors, and alcohol misuse, as well as colorectal cancer screening and influenza vaccinations. CONCLUSIONS This study identifies high-priority preventive services and should help decision makers select which services to emphasize in quality-improvement initiatives.